Rising Global Burden of Gout: Time to Act

AbstractGout is the most common inflammatory arthritis in the world. According to the Global Burden of Disease Study 2017 (GBD 2017), there are 41 million adults with gout worldwide, over twice of the 19 million living with rheumatoid arthritis (RA). Yet, in contrast to the remarkable progress made in the treatment of RA, gout management remains poor despite treatment recommendations by various medical societies including the ACR 2020 guideline. About 70% of patients continue to experience frequent flares and only 27% of patients with incident gout are ultimately started on urate lowering therapy (ULT) within 12 months of diagnosis.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Tags: EDITORIAL Source Type: research